Dryness and painful sex are common. Being told to live with them isn't necessary.

This is the concern women most often mention with a hand on the doorknob, at the very end of the visit, prefaced with "one more thing." It's also among the most treatable things we do — and among the least likely to be raised, by patients or by clinicians. So let's put it in the middle of the room.

What GSM actually is

There's a name for this cluster: genitourinary syndrome of menopause. The tissues of the vulva, vagina, urethra, and bladder are rich in estrogen receptors, and as estrogen declines they become thinner, less elastic, less lubricated, and more fragile. The symptoms follow from the biology:

• Vaginal dryness, burning, itching, or general irritation
• Discomfort or pain with sex — at entry, with depth, or afterward
• Decreased lubrication and reduced sensation
• Light bleeding or spotting after sex from fragile tissue
• Urinary symptoms — urgency, frequency, burning, and recurrent urinary tract infections

That last group surprises people. The urethra and bladder trigone are estrogen-responsive too, which is why treating GSM can meaningfully reduce recurrent UTIs — a connection many women are never told about while being handed repeated courses of antibiotics.

Two things that make GSM different

First: it doesn't resolve on its own. Hot flashes and night sweats typically fade over time. GSM does the opposite — the tissue changes are ongoing, so untreated symptoms tend to progress. Waiting is the one strategy that reliably doesn't work.

Second: it responds beautifully to treatment — and yet it's estimated that only a minority of affected women are ever treated, largely because nobody asks and it feels awkward to volunteer. We ask. Consider this page permission to bring it up before the doorknob moment.

Before we assume it's hormonal

Estrogen decline is the most common cause of these symptoms after 45, but it isn't the only one, and a few of the alternatives are consequential:

• Pelvic floor muscle dysfunction — guarding and tightening (often after months of anticipating pain) that becomes its own source of pain, and responds to pelvic floor physical therapy rather than hormones
• Lichen sclerosus — a skin condition of the vulva causing itching, whitening, and architectural change; treatable with prescription topical therapy — and worth diagnosing, because untreated disease carries scarring and a small increased risk of vulvar cancer. Women with conditions like this are sometimes told there is nothing to be done. There is almost always something to be done
• Vulvodynia, infection, dermatitis, or endometriosis — each with a different path

This is why an actual exam matters. Symptom lists are useful; a diagnosis is better.

Treatment: the full menu, honestly presented

Local (vaginal) estrogen — the mainstay

Low-dose estrogen delivered directly to the tissue that needs it, as a cream, a vaginal insert, or a ring worn for three months. It restores tissue thickness, elasticity, and natural lubrication over a matter of weeks, and it treats the urinary symptoms alongside the vaginal ones.

The point that clears up the most confusion: because absorption into the bloodstream at these doses is minimal, a progestogen is not needed for lining protection when low-dose local estrogen is used alone. This is a different conversation, with a different risk profile, from systemic hormone therapy — and many women who aren't candidates for systemic therapy can still use local estrogen. We go through your history individually, including if you have a personal history of breast cancer, where the decision is made carefully and in coordination with your oncology team.

One practical note for Maui: supply and coverage vary by product, and we'll help you find the version that's both right for you and actually obtainable.

Non-hormonal options that genuinely work

Some women can't use hormones, and some simply prefer not to. This lane is real:

• Moisturizers vs. lubricants — a distinction worth knowing. Moisturizers are used regularly (every few days) to change the tissue's baseline hydration; lubricants are used at the time of sex for friction. Most women benefit from both, and using only a lubricant is the most common reason "I tried something and it didn't help."
• Hyaluronic acid vaginal inserts — a well-studied hormone-free moisturizer option
• Pelvic floor physical therapy and vaginal dilators when muscle guarding is part of the picture
• Prescription non-estrogen options — vaginal DHEA or an oral SERM, depending on your history and preferences

The specific products we recommend, several with practice discounts, are on our patient resources page.

Energy-based treatments, positioned honestly

We offer FemiLift and EmFemme 360 for tissue quality and comfort. We also tell patients the truth about them: the evidence base is still developing and they are best understood as an adjunct — most useful on tissue that is hormonally supported, or for women who cannot use hormones at all. A device is never our opening move, and never sold off a menu.

And when desire is the real question

Pain and desire are tangled: it's difficult to want something that hurts. We treat the tissue first, then look honestly at desire itself — where sleep, mood, medications, relationship context, and sometimes testosterone for HSDD all belong in the conversation.

What to expect from treatment

Most women notice meaningful change within a few weeks, with continued improvement over two to three months as the tissue rebuilds. GSM treatment is generally ongoing — symptoms return if therapy stops, because the underlying estrogen decline hasn't changed — and long-term use of low-dose local therapy is well established. We'll set a follow-up to adjust rather than leaving you to guess whether it's working.

Related: intimate wellness treatments · menopause & hormone therapy · heavy periods · hot flashes · midlife weight · products we trust · FAQ